Sponsor Pipeline

Priovant Therapeutics, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
2
Recruiting
3
Phase 3
Active Trials by Phase
Phase 3
2
Phase 2/3
1
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06431373 A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis Uveitis, Posterior Active, Not Recruiting
NCT05437263 A Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With… Dermatomyositis Active, Not Recruiting
Phase 2/3
NCT07532603 A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris Lichen Planopilaris Recruiting
Phase 2
NCT06978725 A Phase 2 Study of the Safety and Efficacy of Brepocitinib in Adults With Cutaneous… Cutaneous Sarcoidosis Recruiting
Get alerts when Priovant Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free